Catalog

Advanced Echo 2025
Online
Added:03/31/2025 1:22 PM

Advanced Echo 2025 features the latest education on established and emerging cardiovascular ultrasound technologies. Combining the course directorships of Echo Hawaii and State-of-the-Art Echocardiography, expert faculty discuss state-of-the-art technologies with a particular focus on how they can be effectively be applied in the clinical setting. Case-based approaches are used to discuss new and established applications of echocardiography for diagnosis and guiding management in patients with a broad array of cardiovascular conditions.
CME/MOC Credits: 13.75 AMA PRA Category 1 Creditsâ„¢
Release Date: March 31, 2025
Activity Expiration Date: March 31, 2026 - CME/MOC must be claimed by this date.

Credits awarded per Session. See individual Sessions for further details.
Credits awarded
Type
Name
Sub type
Value
Certificate awarded
$420.00
Already successfully completed: re-enrollment available!
Secure Transaction

About this item

Advanced Echo 2025 features the latest education on established and emerging cardiovascular ultrasound technologies. Combining the course directorships of Echo Hawaii and State-of-the-Art Echocardiography, expert faculty discuss state-of-the-art technologies with a particular focus on how they can be effectively be applied in the clinical setting. Case-based approaches are used to discuss new and established applications of echocardiography for diagnosis and guiding management in patients with a broad array of cardiovascular conditions.

CME/MOC Credits: 13.75 AMA PRA Category 1 Credits™ 

Release Date: March 31, 2025
Activity Expiration Date: March 31, 2026 - CME/MOC must be claimed by this date.

 

Course/Activity Information

Learning Objectives

Upon completion of this program, participants will be better able to:

  • Integrate echocardiographic information in clinical decision making.
  • Assess ventricular and valvular function using Doppler hemodynamics.
  • Describe Doppler assessment of diastolic function/dysfunction.
  • Explain new advances in the echocardiographic assessment of left and right ventricular function, including strain and 3D.
  • Integrate echocardiographic assessment of cardiomyopathies and systemic diseases in patient management.
  • Define clinical uses of TEE and 3D echocardiography.
  • Recognize how echocardiography is used to help manage patients with ischemic heart disease.
  • Recognize the role of echo contrast and be able to incorporate its use in the echo laboratory.
  • Integrate echo information in the management of complex valvular heart disease.

CME Information:  The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Echocardiography designates this article for a maximum of 13.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program, the American Board of Pediatrics (ABP) MOC program, and/or the American Board of Anesthesiology’s (ABA) Maintenance of Certification in Anesthesiology Program® or MOCA 2.0®. It is ASE’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABP MOC points and/or ABA MOCA 2.0®.   Participants should claim only the credit commensurate with the extent of their participation in the activity. Physicians will earn MOC and/or MOCA 2.0 points equivalent to the amount of CME credits claimed for the activity.

ARDMSCCI, and Sonography Canada recognize ASE’s certificates and have agreed to honor the CME credit hours toward their registry requirements for sonographers.

Disclosure:

ASE is committed to ensuring that its educational mission, and all accredited continuing educational programs provide a protected space to learn, teach, and engage in scientific discourse free from influence from organizations that may have an incentive to insert commercial bias into education.

While a monetary or professional affiliation with an ineligible company does not necessarily influence a speaker’s presentation, the Standards for Integrity and Independence in Accredited Continuing Education and policies of the ACCME require that all financial relationships with ineligible companies* be identified and mitigated prior to engaging in an accredited CE activity. In accordance with these policies, ASE actively identified relevant financial relationships between faculty in control of this accredited CE activity and ineligible companies and implemented mitigation strategies to eliminate any potential influence from persons or organizations that may have an incentive to insert commercial bias in this activity. (*Companies that are ineligible to be accredited in the ACCME System (“ineligible companies”) are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.)

The following faculty members have no relevant financial relationships with ineligible companies:

  • Theodore Abraham, MD, FASE
  • Federico Asch, MD, FASE
  • Kiran Belani, MD
  • Jerry Estep, MD, FASE
  • Rebecca Hahn, MD, FASE
  • Roberto Lang, MD, FASE
  • Sunil Mankad, MD, FASE
  • Vera Rigolin, MD, FASE
  • Vincent Sorrell, MD, FASE
  • Gregory Scalia, MBBS, FASE
  • Edwin Tucay, MD, FPSE, FASE
  • Cathy West, MSc, AMS, FASE

All relevant financial relationships with ineligible companies listed for the following faculty members have been mitigated:

  • Ana Barac, MD, PhD; Astra Zeneca (Consultant/Advisor)
  • Renuka Jain, MD, FASE; GE Healthcare (Research Funding); Medtronic (Speaker/Speaker's Bureau, Consultant/Advisor)
  • Linda Gilliam, MD, FASE; Medtronic (Consultant/Advisor); Philips (Consultant/Advisor)
  • Noreen Kelly, MD, FASE; Abbott (Speaker/Speaker's Bureau)
  • Dermot Phelan, MD, PhD, FASE; Bristol Myers Squibb (Speaker/Speaker's Bureau); Caption Health (Consultant/Advisor)
  • Muhamed Saric, MD, PhD, FASE; Medtronic (Speaker/Speaker's Bureau); Abbott (Speaker/Speaker's Bureau); Boston Scientific (Speaker/Speaker's Bureau)

Members of the ASE CME Committee members (not serving as faculty) do not have any financial relationships with ineligible companies.  Click here for a list of these members.

None of the ASE staff who were involved in the planning and implementation of this educational activity have relevant financial relationship(s) to disclose with ineligible companies.  Click here for a list of ASE staff members.

Other information

  • Training Hours: 13.75
  • Additional Charges May Apply

    Ratings and reviews

    Close
    Shopping Cart

    Loading Shopping Cart Items...

    Overall Total